Sandoz Group AG (Sandoz Group AG) COGS-to-Revenue : 0.54 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG COGS-to-Revenue?

Sandoz Group AG's Cost of Goods Sold for the three months ended in Dec. 2023 was $5,415 Mil. Its Revenue for the three months ended in Dec. 2023 was $9,979 Mil.

Sandoz Group AG's COGS to Revenue for the three months ended in Dec. 2023 was 0.54.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Sandoz Group AG's Gross Margin % for the three months ended in Dec. 2023 was 45.74%.

Sandoz Group AG COGS-to-Revenue Historical Data

The historical data trend for Sandoz Group AG's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG COGS-to-Revenue Chart

Sandoz Group AG Annual Data

Trend

Dec22

Dec23

COGS-to-Revenue

0.53

0.54

Sandoz Group AG Quarterly Data
	Dec22	Dec23
COGS-to-Revenue	0.53	0.54

Sandoz Group AG COGS-to-Revenue Calculation

Sandoz Group AG's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	5415	/	9979
	=	0.54

Sandoz Group AG's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	5415	/	9979
	=	0.54

Sandoz Group AG (OTCPK:SDZNY) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Sandoz Group AG's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	5415 / 9979
	=	45.74 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Sandoz Group AG COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sandoz Group AG (Sandoz Group AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZNY) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

SDZXF:USA SDZz:UK D8Y0:Germany SDZ:Switzerland

Address

Forum 1, Novartis Campus, Basel, CHE, CH-4056

Website

https://www.sandoz.com

Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as U.S.'s first biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in pipeline.

Sandoz Group AG (Sandoz Group AG) Headlines

From GuruFocus

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024